Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves a new type of schizophrenia drug
FDA approves 1st new drug to treat schizophrenia in more than 30 years
This drug takes the first new approach to schizophrenia treatment in decades," Farchione continued. "This approval offers a new alternative to the antipsychotic medications peo
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.
This FDA-approved drug promises a new way to treat schizophrenia
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies showed Bristol Myers Squibb's drug,
2h
FDA Approves KarXT To Treat Schizophrenia; PureTech Health Gets $29 Mln Milestone Payment
This approval triggers 2 milestone payments totaling $29 million, as per agreements with Royalty Pharma and PureTech's founded entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb ...
BioWorld
10h
Karxt for schizophrenia awaits US FDA decision; inventor opines
Nine years on from securing $3.84 million for a phase I clinical trial to test the formulation, with results showing it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Stadiums to serve as shelters
Kotb leaving 'Today'
World's oldest cheese found
Military recruiting rebounds
Chinese submarine sank
Targeted Black residents?
Boxes to distribute Narcan
Producing doc on Diddy
US sanctions crypto network
Weekly jobless claims fall
Urgent safety alert for 737s
Ending password-sharing
RU hits Ukraine's power grid
NC board removes 747K
More executives leave
Settles defamation lawsuit
50/50 ball ownership suit
To withdraw sickle cell drug
US suicides steady, high
Jan. 6 report delayed
WI duplicate ballot flap
ISR rejects ceasefire talks
On Secret Service failures
NIH finds misconduct
Capital goods orders up
Arrives in Luxembourg
Rose announces retirement
US economy grew
Feedback